Skip to content

Insider · CIK 0001319998

Southpoint Capital Advisors LP

owner

Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing Oct 9, 2025, latest Dec 29, 2025.

In brief

Southpoint Capital Advisors LP files SEC Form 4 as 10% owner at FENC (FENNEC PHARMACEUTICALS INC.). Since Oct 9, 2025, Southpoint Capital Advisors LP has reported 0 open-market buys worth $0 and 4 open-market sells worth $10M, the latest filed on Dec 29, 2025.

A track record needs three past buys with six months of prices behind them; Southpoint Capital Advisors LP has 0, so none is measured yet.

The newest scored trade: sold $7.5M of FENC on Dec 24, 2025, filed Dec 29, 2025, scored 55 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $9.7M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $10M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

FENC: FENNEC PHARMACEUTICALS INC.

FENCOct 12, 2026 · close 10.72

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
55Moderate
FENCsell 2
FENNEC PHARMACEUTICALS INC.
$7.5M
1,000,000 shares
-27%+53% from low-22% from high
31Weak
FENCsell 2
FENNEC PHARMACEUTICALS INC.
$170k
19,341 shares
-1%+117% from low-11% from high
45Moderate
FENCsell 2
FENNEC PHARMACEUTICALS INC.
$2.0M
246,018 shares
-6%+97% from low-20% from high
47Moderate
FENCsell 3
FENNEC PHARMACEUTICALS INC.
$636k
67,114 shares
-2%+138% from low-4% from high

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 24, 2025FENC
FENNEC PHARMACEUTICALS INC.
SOpen-market sale
Common Stockindirect: See Footnote
-1,000,000$7.50$7.5M2,744,741Dec 29, 2025
Nov 18, 2025FENC
FENNEC PHARMACEUTICALS INC.
SOpen-market sale
Common Stockindirect: See Footnote
-19,341$8.79$170k3,744,741Nov 20, 2025
Nov 14, 2025FENC
FENNEC PHARMACEUTICALS INC.
SOpen-market sale
Common Stockindirect: See Footnote
-160,100$8.00$1.3M3,850,000Nov 17, 2025
Nov 17, 2025FENC
FENNEC PHARMACEUTICALS INC.
SOpen-market sale
Common Stockindirect: See Footnote
-85,918$8.79$755k3,764,082Nov 17, 2025
Oct 7, 2025FENC
FENNEC PHARMACEUTICALS INC.
SOpen-market sale
Common Stockindirect: See Footnote
-26,900$9.59$258k4,050,314Oct 9, 2025
Oct 8, 2025FENC
FENNEC PHARMACEUTICALS INC.
SOpen-market sale
Common Stockindirect: See Footnote
-19,605$9.47$186k4,030,709Oct 9, 2025
Oct 9, 2025FENC
FENNEC PHARMACEUTICALS INC.
SOpen-market sale
Common Stockindirect: See Footnote
-20,609$9.35$193k4,010,100Oct 9, 2025

Questions about Southpoint Capital Advisors LP

Answered from the filings on this page, as of the latest one.

Is Southpoint Capital Advisors LP buying or selling?

In the last 12 months Southpoint Capital Advisors LP reported 0 open-market buys worth $0 and 3 open-market sells worth $9.7M on SEC Form 4; the latest was sold $7.5M of FENC on Dec 24, 2025. Grants, option exercises and tax withholding are not counted.

How did Southpoint Capital Advisors LP's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Southpoint Capital Advisors LP has 0.

Where does Southpoint Capital Advisors LP file Form 4?

Southpoint Capital Advisors LP has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Southpoint Capital Advisors LP: insider trades and track record | InsiderTell